0002095512-25-000001.txt : 20251106
0002095512-25-000001.hdr.sgml : 20251106
20251105201107
ACCESSION NUMBER: 0002095512-25-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(1)
ITEM INFORMATION: Section 3(c)(5)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20251106
DATE AS OF CHANGE: 20251105
EFFECTIVENESS DATE: 20251106
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Meridian MVC MedVet Atlanta, LLC
CENTRAL INDEX KEY: 0002095512
ORGANIZATION NAME:
EIN: 393499093
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-563249
FILM NUMBER: 251455669
BUSINESS ADDRESS:
STREET 1: 3811 TURTLE CREEK BLVD., SUITE 875
CITY: DALLAS
STATE: TX
ZIP: 75219-4419
BUSINESS PHONE: (214) 651-4050
MAIL ADDRESS:
STREET 1: 3811 TURTLE CREEK BLVD., SUITE 875
CITY: DALLAS
STATE: TX
ZIP: 75219-4419
D
1
primary_doc.xml
X0708
D
LIVE
0002095512
Meridian MVC MedVet Atlanta, LLC
3811 TURTLE CREEK BLVD., SUITE 875
DALLAS
TX
TEXAS
75219-4419
(214) 651-4050
TEXAS
None
None
Limited Liability Company
true
2025
Curtis
R
Boisfontaine Jr
3811 Turtle Creek Boulevard
Suite 875
Dallas
TX
TEXAS
75219
Executive Officer
Promoter
Manager of the Manager of the Issuer
David
Ronck
3811 Turtle Creek Blvd
Suite 875
Dallas
TX
TEXAS
75219
Executive Officer
Promoter
Mr. Ronck is the Vice President of the Manager of the Issuer.
William
V
Rhame
14180 Dallas Parkway
Suite 715
Dallas
TX
TEXAS
75254
Promoter
Pooled Investment Fund
Other Investment Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.1
- 3C.5
- 3C.7
false
2025-10-21
false
true
false
8635
4500000
4085000
415000
false
36
0
0
0
The Manager, or Affiliates of the Manager, are entitled to an asset management fee, a development services fee, an acquisition fee, a financing fee and a loan guaranty fee.
false
Meridian MVC MedVet Atlanta, LLC
/s/ David Ronck
David Ronck
Vice President of the Manager of the Issuer
2025-11-05